help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on October 11, 2007
Endocrinology, doi:10.1210/en.2007-0690
A more recent version of this article appeared on January 1, 2008
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
149/1/302    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Makeeva, N.
Right arrow Articles by Welsh, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Makeeva, N.
Right arrow Articles by Welsh, N.

Submitted on June 5, 2007
Accepted on October 1, 2007

TAB1{alpha}, but not TAB1{beta}, mediates cytokine-induced p38 MAPK phosphorylation and cell death in insulin producing cells

Natalia Makeeva, Godfried M. Roomans, Jason W. Myers, and Nils Welsh*

Department of Medical Cell Biology, Uppsala University, Sweden, and Department of Biochemistry, Stanford University School of Medicine, Stanford, CA, U.S.A.

* To whom correspondence should be addressed. E-mail: nils.welsh{at}mcb.uu.se.

Previous studies have indicated that the p38 MAPK participates in signaling events that lead to the death of the insulin-producing {beta}-cell. The aim of the present study was to elucidate the role of the transforming growth factor-{beta}-activated protein kinase 1-binding protein 1 (TAB1) in the cytokine-induced activation of p38. Levels of TAB1 mRNA and protein were analyzed by real time PCR and immunoblotting, and TAB1 expression in mouse and human islet cells was down-regulated using lipofection of diced-siRNA. TAB1 over-expression in {beta}-TC6 cells was achieved by transient transfections followed by fluorescence activated cell sorting. Phosphorylation of p38, JNK and ERK was assessed by immunoblotting and viability was determined using vital staining with bisbenzimide and propidium iodide. We observed that TAB1 is expressed in insulin producing cells. Cytokine (IL-1{beta} + IFN-{gamma})-stimulated p38 phosphorylation was significantly increased by TAB1{alpha} overexpression, but not by TAB1{beta} overexpression, in {beta}-TC6 cells. The TAB1{alpha}-augmented p38 phosphorylation was paralleled by an increased cell death rate. Treatment of islet cells with diced-siRNA specific for TAB1, but not for TAK1, resulted in lowered cytokine-induced p38 phosphorylation and protection against cell death. The cytokine-induced phosphorylation of JNK and ERK was not affected by changes in TAB1 levels. Finally, TAB1 phosphorylation was decreased by the p38 inhibitor SB203580. We conclude that TAB1{alpha}, but not TAB1{beta}, plays an important role in the activation of p38 in insulin-producing cells and therefore also in cytokine-induced {beta}-cell death.




This article has been cited by other articles:


Home page
DiabetesHome page
D. Mokhtari, J. W. Myers, and N. Welsh
MAPK Kinase Kinase-1 Is Essential for Cytokine-Induced c-Jun NH2-Terminal Kinase and Nuclear Factor-{kappa}B Activation in Human Pancreatic Islet Cells
Diabetes, July 1, 2008; 57(7): 1896 - 1904.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society